Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -94.69%102.62K | 153.69%1.03M | -92.29%85.85K | -45.98%700.69K | -120.88%-425.6K | 274.19%1.93M | -324.33%-1.92M | -36.09%1.11M | 152.16%1.3M | -196.25%-192.68K |
| Net income from continuing operations | 84.65%-330.31K | 51.81%-79.18K | 73.32%-330.7K | 64.19%-4.45M | 89.75%-895.81K | -36.75%-2.15M | 86.80%-164.33K | -42.43%-1.24M | 31.74%-12.43M | 44.91%-8.74M |
| Operating gains losses | ---- | ---- | ---- | ---1.13M | --0 | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -81.35%240.92K | -83.08%213.67K | -81.10%218.16K | 111.87%4.47M | -12.46%758.95K | 503.06%1.29M | 110.47%1.26M | 170.00%1.15M | 111.40%2.11M | 65.40%867.01K |
| Asset impairment expenditure | ---- | ---- | ---- | -97.13%126.6K | ---- | ---- | ---- | ---- | -56.60%4.42M | ---- |
| Remuneration paid in stock | -90.83%22.11K | -55.51%22.45K | 42.99%88.21K | 19.41%344.9K | -106.23%-8.48K | 2,892.87%241.23K | 66.49%50.47K | -45.99%61.69K | -44.75%288.83K | 183.53%136.23K |
| Deferred tax | --0 | -58.80%224.61K | 9.96%350.78K | -36.72%1.04M | -102.08%-42.21K | --217.03K | 397.91%545.18K | 254.11%319K | 142.90%1.64M | -9.16%2.03M |
| Other non cashItems | 14.33%29.3K | 100.90%9.94K | -32.56%21.43K | 60.44%243.04K | 1,869.48%1.29M | 352.91%25.63K | -2,920.81%-1.1M | -23.03%31.77K | -94.21%151.48K | -97.11%65.44K |
| Change In working capital | -93.91%140.6K | 125.48%640.11K | -133.31%-262.03K | -98.77%62.9K | -150.41%-521.16K | 880.75%2.31M | -255.58%-2.51M | -64.84%786.55K | 447.48%5.12M | 7.59%1.03M |
| -Change in receivables | -53.20%230.72K | 164.11%750.91K | -143.47%-2.88M | -64.98%-1.38M | 460.99%483.88K | 15.12%492.97K | -48.42%-1.17M | -248.24%-1.18M | 51.71%-834.52K | -569.42%-134.04K |
| -Change in inventory | 392.89%88.85K | 133.22%39.14K | -235.06%-132.14K | -82.91%114.09K | -66.96%164.42K | 83.56%-30.33K | -12.25%-117.83K | -78.69%97.84K | 170.61%667.41K | 153.07%497.66K |
| -Change in payables and accrued expense | -109.69%-178.96K | 87.74%-149.95K | 46.91%2.75M | -74.93%1.33M | -274.49%-1.17M | 22,511.87%1.85M | -148.75%-1.22M | -11.64%1.87M | 46.54%5.29M | -64.16%670.22K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -94.69%102.62K | 153.69%1.03M | -92.29%85.85K | -45.98%700.69K | -120.88%-425.6K | 274.19%1.93M | -324.33%-1.92M | -36.09%1.11M | 152.16%1.3M | -196.25%-192.68K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 36.82%-1.26M | -5.73%-1.73M | -42.78%-1.35M | -92.51%-5.64M | -220.95%-1.06M | -535.16%-2M | 5.50%-1.63M | 46.54%-942.58K | -9.42%-2.93M | 169.97%878.2K |
| Net PPE purchase and sale | 36.82%-1.26M | -26.85%-2.88M | 36.74%-193.78K | -92.51%-5.64M | -220.95%-1.06M | -535.16%-2M | 26.28%-2.27M | 25.80%-306.32K | -101.69%-2.93M | 236.06%878.2K |
| Net intangibles purchas and sale | ---- | ---- | -81.06%-1.15M | ---- | ---- | ---- | ---- | 52.88%-636.26K | -24.61%-1.53M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 36.82%-1.26M | -5.73%-1.73M | -42.78%-1.35M | -92.51%-5.64M | -220.95%-1.06M | -535.16%-2M | 5.50%-1.63M | 46.54%-942.58K | -9.42%-2.93M | 169.97%878.2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,490.53%15.02M | -103.15%-105.19K | 831.41%1.87M | 260.67%4.88M | 433.82%1.38M | 81.33%418.35K | 114.76%3.34M | -1,214.92%-256.16K | -42.02%1.35M | -116.41%-413.12K |
| Net issuance payments of debt | -74.75%106.08K | 50.19%-105.19K | -23.81%-317.15K | 290.23%1.31M | 429.27%1.36M | 626.00%420.16K | -33.22%-211.18K | -561.40%-256.16K | -1,899.59%-690.25K | -286.03%-413.12K |
| Net common stock issuance | 1,410,794,400.00%14.11M | --0 | --2.19M | 89.45%3.56M | --0 | -100.00%-1 | --3.56M | --0 | -12.57%1.88M | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | -88.47%18.83K | --18.83K | ---- | ---- | --0 | 12.62%163.32K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---12.81K | --6 | ---1.8K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,490.53%15.02M | -103.15%-105.19K | 831.41%1.87M | 260.67%4.88M | 433.82%1.38M | 81.33%418.35K | 114.76%3.34M | -1,214.92%-256.16K | -42.02%1.35M | -116.41%-413.12K |
| Net cash flow | ||||||||||
| Beginning cash position | -80.68%210.79K | 375.25%1.4M | 61.77%784.43K | -52.65%484.9K | -48.53%190.48K | -19.13%1.09M | -62.62%295.42K | -52.65%484.9K | -77.27%1.02M | -58.56%370.06K |
| Current changes in cash | 3,825.85%13.86M | -272.44%-800.84K | 824.98%613.59K | 80.10%-55.31K | -139.91%-108.72K | 129.57%353.07K | -131.48%-215.02K | -114.45%-84.64K | 90.17%-278.01K | -77.26%272.4K |
| Effect of exchange rate changes | 92.00%-100.28K | -138.81%-392.34K | 105.67%5.94K | 235.92%354.84K | 545.97%702.67K | -684.07%-1.25M | 914.80%1.01M | 45.99%-104.85K | 60.04%-261.07K | 85.23%-157.56K |
| End cash Position | 7,234.63%13.97M | -80.68%210.79K | 375.25%1.4M | 61.77%784.43K | 61.77%784.43K | -48.53%190.48K | -19.13%1.09M | -62.62%295.42K | -52.65%484.9K | -52.65%484.9K |
| Free cash from | -1,677.23%-1.16M | 80.43%-695.65K | -834.58%-1.26M | -202.60%-4.94M | -317.03%-1.49M | 95.42%-65.29K | -307.62%-3.56M | 958.26%171.52K | 68.40%-1.63M | 151.93%685.52K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.